Mumbai: Global pharmaceutical giant Lupin has announced the retirement of its three senior executives.Naresh Gupta, President ...

Lupin's board approves the transfer of its API R&D division to a wholly owned subsidiary. The company also modified an earlier OTC business transfer.

The company had on Feb. 12 intimated regarding the board's approval for the transfer of the OTC Consumer Healthcare Business ...

Lupin Digital Health (LDH), India's leading evidence-based Digital Therapeutics (DTx) platform, today announced the launch of ...

Lupin Digital Health has launched a Post-Procedure Home-Based Care Guide, developed alongside the American College of ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...

Trump had earlier said on March 24 that he will announce tariffs on automobiles, pharmaceuticals and aluminum in the near ...

Amifampridine tablets are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 ...

New patient guides aim to support recovery from heart procedures, reducing complications and hospital readmissions ...

India's Lupin is another generic drugmaker looking to grab a share of the burgeoning obesity treatment market with its own version of Novo's Wegovy. NATCO, MANKIND PHARMA, AUROBINDO PHARMA Media ...